skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 333  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Care And Treatment remove Journal Title: M2 Presswire remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
People with depression see no immediate change from common GP assessment, study shows
Material Type:
Newspaper Article
Add to My Research

People with depression see no immediate change from common GP assessment, study shows

M2 Presswire, 2024-03-28

COPYRIGHT 2024 Normans Media Ltd.

Digital Resources/Online E-Resources

2
Clinique Partners with Icahn School of Medicine at Mount Sinai to Establish the Mount Sinai-Clinique Healthy Skin Dermatology Center
Material Type:
Newspaper Article
Add to My Research

Clinique Partners with Icahn School of Medicine at Mount Sinai to Establish the Mount Sinai-Clinique Healthy Skin Dermatology Center

M2 Presswire, 2024-02-05

COPYRIGHT 2024 Normans Media Ltd.

Digital Resources/Online E-Resources

3
European Commission authorises GSK's Omjjara (momelotinib) | GSK
Material Type:
Newspaper Article
Add to My Research

European Commission authorises GSK's Omjjara (momelotinib) | GSK

M2 Presswire, 2024-01-30

COPYRIGHT 2024 Normans Media Ltd.

Digital Resources/Online E-Resources

4
Over £800m to boost innovation, growth and improve patient safety
Material Type:
Newspaper Article
Add to My Research

Over £800m to boost innovation, growth and improve patient safety

M2 Presswire, 2022-10-14

COPYRIGHT 2022 Normans Media Ltd.

Digital Resources/Online E-Resources

5
Tinnitus Pipeline Research Report 2022: Comprehensive Insights About 8+ Companies and 8+ Pipeline Drugs
Material Type:
Newspaper Article
Add to My Research

Tinnitus Pipeline Research Report 2022: Comprehensive Insights About 8+ Companies and 8+ Pipeline Drugs

M2 Presswire, 2022-07-19

COPYRIGHT 2022 Normans Media Ltd.

Digital Resources/Online E-Resources

6
Parents and Caregivers Report a Reduction in Anxiety and Distress in Young Cancer Patients Using the My Special Aflac Duck
Material Type:
Newspaper Article
Add to My Research

Parents and Caregivers Report a Reduction in Anxiety and Distress in Young Cancer Patients Using the My Special Aflac Duck

M2 Presswire, 2024-04-09

COPYRIGHT 2024 Normans Media Ltd.

Digital Resources/Online E-Resources

7
Chronic Myeloid Leukemia Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Kiadis Pharma, BioLineRx, Ltd
Material Type:
Newspaper Article
Add to My Research

Chronic Myeloid Leukemia Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Kiadis Pharma, BioLineRx, Ltd

M2 Presswire, 2024-04-04

COPYRIGHT 2024 Normans Media Ltd.

Digital Resources/Online E-Resources

8
Bronchiolitis Obliterans Syndrome Key Companies, Emerging Therapies, and Pipeline Assessment
Material Type:
Newspaper Article
Add to My Research

Bronchiolitis Obliterans Syndrome Key Companies, Emerging Therapies, and Pipeline Assessment

M2 Presswire, 2021-05-12

COPYRIGHT 2021 Normans Media Ltd.

Digital Resources/Online E-Resources

9
Non-Hodgkin Lymphoma Pipeline Assessment 2024: FDA Approvals, Therapies, Clinical Trials and Key Companies involved by DelveInsight | AstraZeneca, Baxter, Bayer, Bristol Myers Squibb, Teva Pharma
Material Type:
Newspaper Article
Add to My Research

Non-Hodgkin Lymphoma Pipeline Assessment 2024: FDA Approvals, Therapies, Clinical Trials and Key Companies involved by DelveInsight | AstraZeneca, Baxter, Bayer, Bristol Myers Squibb, Teva Pharma

M2 Presswire, 2024-03-08

COPYRIGHT 2024 Normans Media Ltd.

Digital Resources/Online E-Resources

10
Advanced Ovarian Cancer Pipeline Analysis, 2024 Updates | Latest FDA, EMA, and PMDA Approvals | Pfizer, Daiichi Sankyo, Astellas Pharma, Jiangsu HengRui, Boehringer Ingelheim, Impact Therapeutics
Material Type:
Newspaper Article
Add to My Research

Advanced Ovarian Cancer Pipeline Analysis, 2024 Updates | Latest FDA, EMA, and PMDA Approvals | Pfizer, Daiichi Sankyo, Astellas Pharma, Jiangsu HengRui, Boehringer Ingelheim, Impact Therapeutics

M2 Presswire, 2024-03-01

COPYRIGHT 2024 Normans Media Ltd.

Digital Resources/Online E-Resources

11
Chronic Lymphocytic Leukemia Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Janssen RD, NovalGen, Genmab, Ascentage
Material Type:
Newspaper Article
Add to My Research

Chronic Lymphocytic Leukemia Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Janssen RD, NovalGen, Genmab, Ascentage

M2 Presswire, 2024-02-21

COPYRIGHT 2024 Normans Media Ltd.

Digital Resources/Online E-Resources

12
HER2-Positive Breast Cancer Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, and Treatment Outlook | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, Ambrx
Material Type:
Newspaper Article
Add to My Research

HER2-Positive Breast Cancer Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, and Treatment Outlook | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, Ambrx

M2 Presswire, 2023-12-08

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

13
Bone Therapeutics treats first patients in ALLOB Phase IIb tibial fracture study
Material Type:
Newspaper Article
Add to My Research

Bone Therapeutics treats first patients in ALLOB Phase IIb tibial fracture study

M2 Presswire, 2021-01-12

COPYRIGHT 2021 Normans Media Ltd.

Digital Resources/Online E-Resources

14
Trial results give hope to patients with severe eye condition
Material Type:
Newspaper Article
Add to My Research

Trial results give hope to patients with severe eye condition

M2 Presswire, 2023-10-27

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

15
Metastatic Pancreatic Cancer Pipeline, Clinical Trials Assessment, NDA Approvals 2023 (Updated) | Salspera, BioLineRx, Ocuphire Pharma, Incyte Corporation, Eli Lilly and Company, Rexahn
Material Type:
Newspaper Article
Add to My Research

Metastatic Pancreatic Cancer Pipeline, Clinical Trials Assessment, NDA Approvals 2023 (Updated) | Salspera, BioLineRx, Ocuphire Pharma, Incyte Corporation, Eli Lilly and Company, Rexahn

M2 Presswire, 2023-07-17

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

16
Inflammatory Pain Pipeline and Clinical Trials Pipeline Analysis 2023 (Updated): 3+ Companies are working to improve the Treatment of Space | Norpharma, Parexel, Pfizer, GE Healthcare, and others
Material Type:
Newspaper Article
Add to My Research

Inflammatory Pain Pipeline and Clinical Trials Pipeline Analysis 2023 (Updated): 3+ Companies are working to improve the Treatment of Space | Norpharma, Parexel, Pfizer, GE Healthcare, and others

M2 Presswire, 2023-07-17

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

17
Grifols meets enrollment target in phase 3 study of two dose regimens of Prolastinreg;-C in patients with emphysema due to alpha-1-antitrypsin deficiency
Material Type:
Newspaper Article
Add to My Research

Grifols meets enrollment target in phase 3 study of two dose regimens of Prolastinreg;-C in patients with emphysema due to alpha-1-antitrypsin deficiency

M2 Presswire, 2023-07-14

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

18
Grifols meets enrollment target in phase 3 study of two dose regimens of Prolastin®-C in patients with emphysema due to alpha-1-antitrypsin deficiency
Material Type:
Newspaper Article
Add to My Research

Grifols meets enrollment target in phase 3 study of two dose regimens of Prolastin®-C in patients with emphysema due to alpha-1-antitrypsin deficiency

M2 Presswire, 2023-07-14

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

19
Ayurveda Introduces a Revolutionary Treatment for Kidney Failure Without Dialysis
Material Type:
Newspaper Article
Add to My Research

Ayurveda Introduces a Revolutionary Treatment for Kidney Failure Without Dialysis

M2 Presswire, 2023-03-20

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

20
Addiction Disorders Drugs Market Report 2022: Increasing Prevalence of Addictive Substances Such as Alcohol, Tobacco, and Drugs Among All Age Groups Drives Growth
Material Type:
Newspaper Article
Add to My Research

Addiction Disorders Drugs Market Report 2022: Increasing Prevalence of Addictive Substances Such as Alcohol, Tobacco, and Drugs Among All Age Groups Drives Growth

M2 Presswire, 2023-01-16

COPYRIGHT 2023 Normans Media Ltd.

Digital Resources/Online E-Resources

Results 1 - 20 of 333  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2011  (33)
  2. 2011 To 2012  (84)
  3. 2013 To 2015  (20)
  4. 2016 To 2018  (3)
  5. After 2018  (194)
  6. More options open sub menu

Searching Remote Databases, Please Wait